AzTrials
AzTrials

Drug AbuseNCT04461314

Hotline Service for Drug-abusing Youth and Young Adults

A study testing peer-led counselling in people with Drug Abuse, run by The University of Hong Kong at 1 site in Hong Kong.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Aim: Providing peer counselling service delivered by student counsellors with a medical background via a hotline to drug-abusing youth and young adult aged 35 or below. Objectives: i. Read more about this study

Who is it for?
Ages Up to 35 years
Conditions the study is for
Drug Abuse
What is being tested?
peer-led counselling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteHong Kong
Study dates
26 Aug 2020to Aug 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 35 years
  • All sexes
  • No healthy volunteers
  • Child, Adult

Who may be able to join

  • The inclusion criteria of target service group for this quitline programme is that current drug abusers in Hong Kong who should (1) be aged 35 or below, (2) be able to communicate in Cantonese, and (3) have a history of drug abuse within the past 12 months (including all types of drugs such as narcotics analgesics, hallucinogens, depressants, stimulants, tranquillizers and other recreational drugs).
  • The inclusion criteria of peer counsellors providing counselling service in this quitline programme are those who should (1) be aged 18 - 35, (2) be able to communicate in Cantonese, (3) have a medical background, (4) complete the training courses and pass the evaluation of peer counsellor qualification.

Who cannot join

  • Those who are psychologically or physically unable to communicate will be excluded.

Trial locations and contacts

1 site in 1 country.

Ho Cheung William Li, PhD contact

+85239176634

william3@hku.hk

Wei Xia, PhD contact

+85239176650

xiavive@hku.hk

Hong Kong1 site, 1 recruiting
  • The University of Hong Kong

    Hong Kong, Pokfulam

    Ho Cheung William Li, PhD, +85239176634, william3@hku.hk

    Recruiting

Other trials in Hong Kong

About this study

Official title: MedPAC Hotline: A Medical Peer Addiction Counselling Hotline Service for Drug-abusing Youth and Young Adults

Aim: Providing peer counselling service delivered by student counsellors with a medical background via a hotline to drug-abusing youth and young adult aged 35 or below.

Objectives:

  1. To raise anti-drug awareness of young people in general and identify high-risk/hidden drug-abusing youth and young adult aged 35 or below in Hong Kong; and ii. To train university students with a medical background as peer counsellors; and iii. To provide drug abuse hotline service by students with a medical background as peer counsellors to drug-abusing youth and young adult aged 35 or below, and other people who call for help, including drug abusers' family members, friends, and professionals; and iv. To improve the drug-abusing youth and young adult' knowledge about the hazard of drug abuse, negative attitude, and perception towards the drug abuse through the telephone peer counselling service provided by students with medical background; and v. To increase the intention to quit and the help-seeking behavior among the drug-abusing youth and young adult; vi. To increase reduction rate and abstinence rate from drug abuse, and decrease the relapse rate among drug-abusing youth and young adult through the telephone peer counseling service.
Read the detailed description

The MedPAC Hotline Service will be promoted to high-risk and drug-abusing youth and young adults through a variety of platforms, namely schools and youth service organizations, industries, community, mass media and internet, social media, posters and snowball approach.

The hotline service will operate from 5 p.m. to 9 p.m. on weekday and from 2 p.m. to 8 p.m. on weekend. A peer counsellor or a research assistant will answer the telephone inquiries from 9:30 a.m. to 5 p.m. on weekdays.

About 50 university students will be trained as peer counsellors through a structured training programme. The students will be invited to complete the pre, post and 6-month self-administered questionnaire before, immediately and 6-month after the training programme to examine their changes of knowledge of and attitudes towards addiction counselling. A satisfaction survey will also be conducted to measure their perception on the quality of training programme.

Peer counsellors will use telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to motivate and encourage drug-abusing or high-risk youth and young adults to rehabilitate from drug abuse, assist them to manage the withdrawal symptoms, and help identify barriers and facilitators to rehabilitate from drug abuse in the telephone counselling. The peer counsellors will give referral advices if the youth and young adult needs appropriated treatment and rehabilitation services.

The drug-abusing youth and young adults will be counselled and invited to complete the follow-up questionnaires over the telephone after joining the MedPAC Hotline Service programme for 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups were invited to have urine test to validate the drug abuse abstinence status.

Conditions
Drug Abuse
Being tested
peer-led counselling
Keywords
Youth, Hotline, Drug abuse, Young Adult, Addiction
Medical subject headings
Substance-Related Disorders, Behavior, Addictive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • peer-led counsellingBehavioural

    About 50 university students will be trained as peer counsellors through a structured training programme. A pre and post and 6-month self-administered questionnaire will be conducted before, immediately and 6-month after the training programme to examine their changes of knowledge and attitudes. A satisfaction survey will also be conducted to measure participants' perception of the quality of the training programme.

    Drug-abusing youth and young adults will receive telephone-based, Peer-led Brief Motivational Interviewing (BMI) counselling to rehabilitate from drug abuse. The peer counsellors will give referral advice if the youth and young adult needs appropriate treatment and rehabilitation services.

    The drug abusers will be counselled and invited to complete the follow-up questionnaires at 1 week, 1 month, 3 months, 6 months, 9 months and 1 year. Self-reported quitters at 6-month and 1-year follow-ups will be invited to have a urine test to validate the drug abuse abstinence.

Study groups in NCT04461314
Study groupRoleWhat they receive
Peer-led counsellingOther1. About 50 university students trained as peer telephone counsellors through a structured training programme. 2. About 200 Drug-abusing youth and young adults received telephone-based, Peer-led Brief Motivational Interviewing (BMI)
Receives: Behavioral: peer-led counselling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in drug consumption at 12-month follow-up

    Drug abuser's drug consumption is measured at 12-month follow-up. A questionnaire asking the frequency of drug use in the past 30 days will be used for assessing the self-reported change in drug consumption.

    Measured: Baseline and 12 months

Secondary outcomes (9)
  1. 30 days self-reported drug abstinence at 6-month and 12-month follow-up

    Self-reported drug abstinence (do not use drug for at least 30 days during the time of follow-up) at 6-month and 12-month. A questionnaire asking the drug use status, quitting experience will be used for assessing the self-reported drug abstinence.

    Measured: Baseline, 6 months and 12 months

  2. Change in drug consumption at 6-month follow-up

    Drug abuser's drug consumption is measured at 6-month follow-up. A questionnaire asking the frequency of drug use in the past 30 days will br used for assessing the self-reported change in drug consumption.

    Measured: Baseline and 6 months

  3. Change in relapse risk among the quitters

    Drug quitter's relapse risk is measured at 12-month follow-up. A questionnaire using Stimulant Relapse Risk Scale (SRRS) with the questions of the intention to use drugs, compulsivity for drugs and impetus and confidence to avoid drugs etc. will be used for assessing the relapse risk at 12-month follow-up. The higher the scores, the higher the relapse risk.

    Measured: Baseline and 12 months

  4. Change of the contemplation stage

    Drug abuser's change of the contemplation stage at 6-month and 12-month follow-up. A questionnaire asking the intention to quit drug abuse and experience of drug abstinence to match the stage in contemplation ladder will be used for assessing the contemplation stage at 6-month and 12-month.

    Measured: Baseline, 6 months and 12 months

  5. Changes of the perceived treatment needs and motivation towards solving the problem of drug abuse

    Drug abuser's change of perceived treatment needs and motivation towards solving the problem among drug abusers at 6-month and 12-month. A questionnaire using the Treatment Needs/Motivation Scales (TCU MOTForm) will be used for assessing the level of the intention and motivation to receive treatment of solving the drug abuse problem. The higher the scores, the higher the perceived treatment needs and motivation.

    Measured: Baseline, 6 months and 12 months

  6. Change of self-efficacy of drug abusers to avoid drug use

    Drug abuser's change of self-efficacy to avoid drug use at 6-month and 12-month follow-up. The Adolescent Relapse Coping Questionnaire (ARCQ) will be used for evaluating the self-efficacy to avoid drug use. It comprises 6 questions for a given condition about drug temptation. The higher the score, the higher the self-efficacy of drug abusers to avoid drug use.

    Measured: Baseline, 6 months and 12 months

  7. Drug abuser's improvement of knowledge and attitude on drug abuse hazards

    Drug abuser's improvement of knowledge and attitude on drug abuse hazards at 6-month and 12-month follow-up. A questionnaire asking about the knowledge and attitude on drug abuse with a scale called "knowledge and attitude on drug abuse for drug abuser" will be used for assessing the change of knowledge and attitude on drug abuse. The higher the scores, the better the knowledge and attitude.

    Measured: Baseline, 6 months and 12 months

  8. Peer counsellor's improvement of knowledge and attitude on drug abuse hazards

    Peer counsellor's improvement of knowledge and attitude on drug abuse hazards immediately after the training programme and after 6 months will be measured by a scale called "knowledge and attitude on drug abuse for peer counsellor" in a self-reporting structured questionnaire. The higher the scores, the better the knowledge and attitude.

    Measured: Baseline, immediately after the training programme and 6 months

  9. Satisfaction of peer counsellors to the drug abuse training programme

    Satisfaction of peer counsellors to the drug abuse training programme will be collected. A questionnaire asking about the comments of content, practicability, speakers from the peer counsellors with the satisfaction scale will be used for evaluating the satisfaction immediately after the training programme. The higher the scores, the greater the satisfaction of the training programme.

    Measured: Immediately after the training programme

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jul 2020
  2. Study start26 Aug 2020
  3. Primary completionAug 2023 (estimated)
  4. Study completionAug 2023 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Health services research
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04461314
Sponsor's protocol ID
MedPAC Hotline
Status last verified
Jul 2020
First submitted
15 Jun 2020
Last updated
4 Nov 2020
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The relevant anonymized patient-level data, full dataset, technical appendix, and statistical code are available on reasonable request. The approval from the Principal Investigator for the purpose of data use is required.

Publications

  • Xia W, Li HCW, Liang T, Luo Y, Ho LLK, Cheung AT, Song P. Structured online training for university students to deliver peer-led addiction counselling for young drug abusers in China: Effect on improving knowledge, attitude, confidence, and skills. Patient Educ Couns. 2022 Apr;105(4):1009-1017. doi: 10.1016/j.pec.2021.07.038. Epub 2021 Jul 24.

    PubMed 34334262

Questions about this trial

What is this clinical trial studying?

A study testing peer-led counselling in people with Drug Abuse, run by The University of Hong Kong at 1 site in Hong Kong.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 4 Nov 2020. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Hong Kong. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Ho Cheung William Li, PhD (+85239176634, william3@hku.hk), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in drug consumption at 12-month follow-up (time frame: Baseline and 12 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04461314, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Nov 2020.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in